|
11DR
Human Brain RNA Vault Shoulder bound to ADPR, focused refinement (EMPIAR-10766)
Deposited 2026-02-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
Chain C
1–893(893 aa)
|
Not recorded
|
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.62 Å
|
|
11DV
RNA Vault waist region, focused refinement (MVP/TEP1 sample)
Deposited 2026-02-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
Chain C
1–893(893 aa)
Chain D
1–893(893 aa)
Chain E
1–893(893 aa)
Chain F
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;50 mM Tris 7.5
75 NaCl
1.5 mM MgCl2
1 mM DTT
1 mM BAD
1 mM AMP-PNP
0.025% DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.33 Å
|
|
11EE
RNA Vault shoulder region with BAD bound, focused refinement (MVP/TEP1 sample)
Deposited 2026-02-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
Chain C
1–893(893 aa)
|
Not recorded
|
DQV [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5S)-5-(3-carbamoylphenyl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;50 mM Tris 7.5
75 NaCl
1.5 mM MgCl2
1 mM DTT
1 mM BAD
1 mM AMP-PNP
0.025% DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.87 Å
|
|
11EQ
RNA Vault with BAD bound (MVP/TEP1 sample)
Deposited 2026-02-19
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 78
PDB declaration: 78-meric
|
Chain 0
1–893(893 aa)
Chain 1
1–893(893 aa)
Chain 2
1–893(893 aa)
Chain 3
1–893(893 aa)
Chain 4
1–893(893 aa)
Chain 5
1–893(893 aa)
Chain 6
1–893(893 aa)
Chain 7
1–893(893 aa)
Chain 8
1–893(893 aa)
Chain 9
1–893(893 aa)
Chain A
1–893(893 aa)
Chain AA
1–893(893 aa)
Chain AB
1–893(893 aa)
Chain AC
1–893(893 aa)
Chain AD
1–893(893 aa)
Chain AE
1–893(893 aa)
Chain AF
1–893(893 aa)
Chain AG
1–893(893 aa)
Chain AH
1–893(893 aa)
Chain AI
1–893(893 aa)
Chain AJ
1–893(893 aa)
Chain AK
1–893(893 aa)
Chain AL
1–893(893 aa)
Chain AM
1–893(893 aa)
Chain AN
1–893(893 aa)
Chain AO
1–893(893 aa)
Chain AP
1–893(893 aa)
Chain B
1–893(893 aa)
Chain C
1–893(893 aa)
Chain D
1–893(893 aa)
Chain E
1–893(893 aa)
Chain F
1–893(893 aa)
Chain G
1–893(893 aa)
Chain H
1–893(893 aa)
Chain I
1–893(893 aa)
Chain J
1–893(893 aa)
Chain K
1–893(893 aa)
Chain L
1–893(893 aa)
Chain M
1–893(893 aa)
Chain N
1–893(893 aa)
Chain O
1–893(893 aa)
Chain P
1–893(893 aa)
Chain Q
1–893(893 aa)
Chain R
1–893(893 aa)
Chain S
1–893(893 aa)
Chain T
1–893(893 aa)
Chain U
1–893(893 aa)
Chain V
1–893(893 aa)
Chain W
1–893(893 aa)
Chain X
1–893(893 aa)
Chain Y
1–893(893 aa)
Chain Z
1–893(893 aa)
Chain a
1–893(893 aa)
Chain b
1–893(893 aa)
Chain c
1–893(893 aa)
Chain d
1–893(893 aa)
Chain e
1–893(893 aa)
Chain f
1–893(893 aa)
Chain g
1–893(893 aa)
Chain h
1–893(893 aa)
Chain i
1–893(893 aa)
Chain j
1–893(893 aa)
Chain k
1–893(893 aa)
Chain l
1–893(893 aa)
Chain m
1–893(893 aa)
Chain n
1–893(893 aa)
Chain o
1–893(893 aa)
Chain p
1–893(893 aa)
Chain q
1–893(893 aa)
Chain r
1–893(893 aa)
Chain s
1–893(893 aa)
Chain t
1–893(893 aa)
Chain u
1–893(893 aa)
Chain v
1–893(893 aa)
Chain w
1–893(893 aa)
Chain x
1–893(893 aa)
Chain y
1–893(893 aa)
Chain z
1–893(893 aa)
|
Not recorded
|
DQV [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5S)-5-(3-carbamoylphenyl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) × 78
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;50 mM Tris 7.5
75 NaCl
1.5 mM MgCl2
1 mM DTT
1 mM BAD
1 mM AMP-PNP
0.025% DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.17 Å
|
|
11FH
RNA Vault cap (MVP/PARP4/TEP1 sample)
Deposited 2026-02-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 39
PDB declaration: 39-meric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
Chain C
1–893(893 aa)
Chain D
1–893(893 aa)
Chain E
1–893(893 aa)
Chain F
1–893(893 aa)
Chain G
1–893(893 aa)
Chain H
1–893(893 aa)
Chain I
1–893(893 aa)
Chain J
1–893(893 aa)
Chain K
1–893(893 aa)
Chain L
1–893(893 aa)
Chain M
1–893(893 aa)
Chain N
1–893(893 aa)
Chain O
1–893(893 aa)
Chain P
1–893(893 aa)
Chain Q
1–893(893 aa)
Chain R
1–893(893 aa)
Chain S
1–893(893 aa)
Chain T
1–893(893 aa)
Chain U
1–893(893 aa)
Chain V
1–893(893 aa)
Chain W
1–893(893 aa)
Chain X
1–893(893 aa)
Chain Y
1–893(893 aa)
Chain Z
1–893(893 aa)
Chain a
1–893(893 aa)
Chain b
1–893(893 aa)
Chain c
1–893(893 aa)
Chain d
1–893(893 aa)
Chain e
1–893(893 aa)
Chain f
1–893(893 aa)
Chain g
1–893(893 aa)
Chain h
1–893(893 aa)
Chain i
1–893(893 aa)
Chain j
1–893(893 aa)
Chain k
1–893(893 aa)
Chain l
1–893(893 aa)
Chain m
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM Tris
150 mM NaCl
1 mM DTT
1 mM NADP
0.025% DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.92 Å
|
|
11JC
RNA Vault Shoulder with ADPR bound, compact conformation, focused refinement (MVP/PARP4/TEP1 NADP sample)
Deposited 2026-02-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
Chain C
1–893(893 aa)
|
Not recorded
|
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 Tris 8.0, 75 mM NaCl, 1.5 mM MgCl2, 1 mM DTT, 1 mM NADP, 0.025% DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.96 Å
|
|
11JD
RNA Vault Shoulder with ADPR bound, extended conformation, focused refinement (MVP/PARP4/TEP1 NADP sample)
Deposited 2026-02-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
Chain C
1–893(893 aa)
|
Not recorded
|
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 Tris 8.0, 75 mM NaCl, 1.5 mM MgCl2, 1 mM DTT, 1 mM NADP, 0.025% DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.37 Å
|
|
11JF
RNA Vault bound to PARP4 MINT, focused refinement (MVP/PARP4/TEP1 NADP sample)
Deposited 2026-02-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 Tris 8.0, 75 mM NaCl, 1.5 mM MgCl2, 1 mM DTT, 1 mM NADP, 0.025% DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.85 Å
|
|
1Y7X
Solution structure of a two-repeat fragment of major vault protein
Deposited 2004-12-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
113–221(109 aa)
Fragment:domains 3-4 of MVP repeats (residues 113-221)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.8;303 K;Ionic strength (raw mmCIF value) 150mM NaCl;Pressure ambient
NMR sample composition
1mM MVP U-15N, 20mM bis-Tris, 150mM NaCl, 2mM CaCl2, 15mM DTT, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1mM MVP, 20mM bis-Tris, 150mM NaCl, 2mM CaCl2, 15mM DTT, 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
9BW5
Human Vault Cage
Deposited 2024-05-20
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 78
PDB declaration: 78-meric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE;Vitrification carried out under standard conditions
|
Resolution 3.30 Å
|
|
9BW6
Human Vault Cage in complex with PARP4
Deposited 2024-05-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 156
PDB declaration: 156-meric
|
Chain A
1–893(893 aa)
Chain C
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE;Vitrification carried out under standard conditions
|
Resolution 2.90 Å
|
|
9BW6
Human Vault Cage in complex with PARP4
Deposited 2024-05-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–893(893 aa)
Chain C
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE;Vitrification carried out under standard conditions
|
Resolution 2.90 Å
|
|
9BW7
Human Vault Cage in complex with PARP4 and NAD+
Deposited 2024-05-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 156
PDB declaration: 156-meric
|
Chain A
1–893(893 aa)
Chain C
1–893(893 aa)
|
Not recorded
|
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 78
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE;Vitrification carried out under standard conditions
|
Resolution 2.90 Å
|
|
9BW7
Human Vault Cage in complex with PARP4 and NAD+
Deposited 2024-05-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–893(893 aa)
Chain C
1–893(893 aa)
|
Not recorded
|
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE;Vitrification carried out under standard conditions
|
Resolution 2.90 Å
|
|
9MXH
Human Vault Cage in complex with NAD+
Deposited 2025-01-20
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 78
PDB declaration: 78-meric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
|
Not recorded
|
NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 78
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES pH 8, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.07 Å
|
|
9MXJ
Human Vault Cage in complex with ADP-ribose
Deposited 2025-01-20
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 78
PDB declaration: 78-meric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
|
Not recorded
|
APR ADENOSINE-5-DIPHOSPHORIBOSE × 78
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE;Vitrification carried out under standard conditions
|
Resolution 3.49 Å
|
|
9MXJ
Human Vault Cage in complex with ADP-ribose
Deposited 2025-01-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
|
Not recorded
|
APR ADENOSINE-5-DIPHOSPHORIBOSE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE;Vitrification carried out under standard conditions
|
Resolution 3.49 Å
|
|
9MXJ
Human Vault Cage in complex with ADP-ribose
Deposited 2025-01-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
|
Not recorded
|
APR ADENOSINE-5-DIPHOSPHORIBOSE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE;Vitrification carried out under standard conditions
|
Resolution 3.49 Å
|
|
9MXV
Human Vault Cage in complex with ADP
Deposited 2025-01-21
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 78
PDB declaration: 78-meric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 78
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES pH 8.0, 5 mM CaCl2, 5 mM MgCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.68 Å
|
|
9MXV
Human Vault Cage in complex with ADP
Deposited 2025-01-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES pH 8.0, 5 mM CaCl2, 5 mM MgCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.68 Å
|
|
9MXV
Human Vault Cage in complex with ADP
Deposited 2025-01-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–893(893 aa)
Chain B
1–893(893 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50 mM HEPES pH 8.0, 5 mM CaCl2, 5 mM MgCl2, 0.25 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.68 Å
|
|
9QW9
Human vault protein - primed conformation
Deposited 2025-04-14
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 78
PDB declaration: 78-meric
|
Chain A
1–893(893 aa)
Chain AA
1–893(893 aa)
Chain AB
1–893(893 aa)
Chain AC
1–893(893 aa)
Chain B
1–893(893 aa)
Chain BA
1–893(893 aa)
Chain BB
1–893(893 aa)
Chain C
1–893(893 aa)
Chain CA
1–893(893 aa)
Chain CB
1–893(893 aa)
Chain D
1–893(893 aa)
Chain DA
1–893(893 aa)
Chain DB
1–893(893 aa)
Chain E
1–893(893 aa)
Chain EA
1–893(893 aa)
Chain EB
1–893(893 aa)
Chain F
1–893(893 aa)
Chain FA
1–893(893 aa)
Chain FB
1–893(893 aa)
Chain G
1–893(893 aa)
Chain GA
1–893(893 aa)
Chain GB
1–893(893 aa)
Chain H
1–893(893 aa)
Chain HA
1–893(893 aa)
Chain HB
1–893(893 aa)
Chain I
1–893(893 aa)
Chain IA
1–893(893 aa)
Chain IB
1–893(893 aa)
Chain J
1–893(893 aa)
Chain JA
1–893(893 aa)
Chain JB
1–893(893 aa)
Chain K
1–893(893 aa)
Chain KA
1–893(893 aa)
Chain KB
1–893(893 aa)
Chain L
1–893(893 aa)
Chain LA
1–893(893 aa)
Chain LB
1–893(893 aa)
Chain M
1–893(893 aa)
Chain MA
1–893(893 aa)
Chain MB
1–893(893 aa)
Chain N
1–893(893 aa)
Chain NA
1–893(893 aa)
Chain NB
1–893(893 aa)
Chain O
1–893(893 aa)
Chain OA
1–893(893 aa)
Chain OB
1–893(893 aa)
Chain P
1–893(893 aa)
Chain PA
1–893(893 aa)
Chain PB
1–893(893 aa)
Chain Q
1–893(893 aa)
Chain QA
1–893(893 aa)
Chain QB
1–893(893 aa)
Chain R
1–893(893 aa)
Chain RA
1–893(893 aa)
Chain RB
1–893(893 aa)
Chain S
1–893(893 aa)
Chain SA
1–893(893 aa)
Chain SB
1–893(893 aa)
Chain T
1–893(893 aa)
Chain TA
1–893(893 aa)
Chain TB
1–893(893 aa)
Chain UA
1–893(893 aa)
Chain UB
1–893(893 aa)
Chain V
1–893(893 aa)
Chain VA
1–893(893 aa)
Chain VB
1–893(893 aa)
Chain W
1–893(893 aa)
Chain WA
1–893(893 aa)
Chain WB
1–893(893 aa)
Chain X
1–893(893 aa)
Chain XA
1–893(893 aa)
Chain XB
1–893(893 aa)
Chain Y
1–893(893 aa)
Chain YA
1–893(893 aa)
Chain YB
1–893(893 aa)
Chain Z
1–893(893 aa)
Chain ZA
1–893(893 aa)
Chain ZB
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;25 mM HEPES, 150 mM NaCl, 5 mM CaCl2, 1mM TCEP, pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.09 Å
|
|
9QWQ
Human vault protein - committed conformation
Deposited 2025-04-15
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 78
PDB declaration: 78-meric
|
Chain A
1–893(893 aa)
Chain AA
1–893(893 aa)
Chain AB
1–893(893 aa)
Chain AC
1–893(893 aa)
Chain B
1–893(893 aa)
Chain BA
1–893(893 aa)
Chain BB
1–893(893 aa)
Chain C
1–893(893 aa)
Chain CA
1–893(893 aa)
Chain CB
1–893(893 aa)
Chain D
1–893(893 aa)
Chain DA
1–893(893 aa)
Chain DB
1–893(893 aa)
Chain E
1–893(893 aa)
Chain EA
1–893(893 aa)
Chain EB
1–893(893 aa)
Chain F
1–893(893 aa)
Chain FA
1–893(893 aa)
Chain FB
1–893(893 aa)
Chain G
1–893(893 aa)
Chain GA
1–893(893 aa)
Chain GB
1–893(893 aa)
Chain H
1–893(893 aa)
Chain HA
1–893(893 aa)
Chain HB
1–893(893 aa)
Chain I
1–893(893 aa)
Chain IA
1–893(893 aa)
Chain IB
1–893(893 aa)
Chain J
1–893(893 aa)
Chain JA
1–893(893 aa)
Chain JB
1–893(893 aa)
Chain K
1–893(893 aa)
Chain KA
1–893(893 aa)
Chain KB
1–893(893 aa)
Chain L
1–893(893 aa)
Chain LA
1–893(893 aa)
Chain LB
1–893(893 aa)
Chain M
1–893(893 aa)
Chain MA
1–893(893 aa)
Chain MB
1–893(893 aa)
Chain N
1–893(893 aa)
Chain NA
1–893(893 aa)
Chain NB
1–893(893 aa)
Chain O
1–893(893 aa)
Chain OA
1–893(893 aa)
Chain OB
1–893(893 aa)
Chain P
1–893(893 aa)
Chain PA
1–893(893 aa)
Chain PB
1–893(893 aa)
Chain Q
1–893(893 aa)
Chain QA
1–893(893 aa)
Chain QB
1–893(893 aa)
Chain R
1–893(893 aa)
Chain RA
1–893(893 aa)
Chain RB
1–893(893 aa)
Chain S
1–893(893 aa)
Chain SA
1–893(893 aa)
Chain SB
1–893(893 aa)
Chain T
1–893(893 aa)
Chain TA
1–893(893 aa)
Chain TB
1–893(893 aa)
Chain UA
1–893(893 aa)
Chain UB
1–893(893 aa)
Chain V
1–893(893 aa)
Chain VA
1–893(893 aa)
Chain VB
1–893(893 aa)
Chain W
1–893(893 aa)
Chain WA
1–893(893 aa)
Chain WB
1–893(893 aa)
Chain X
1–893(893 aa)
Chain XA
1–893(893 aa)
Chain XB
1–893(893 aa)
Chain Y
1–893(893 aa)
Chain YA
1–893(893 aa)
Chain YB
1–893(893 aa)
Chain Z
1–893(893 aa)
Chain ZA
1–893(893 aa)
Chain ZB
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;25 mM HEPES, 150 mM NaCl, 5 mM CaCl2, 1mM TCEP, pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.45 Å
|
|
9R86
Major Vault Protein from Human Brain
Deposited 2025-05-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 39
PDB declaration: 39-meric
|
Chain A0
1–893(893 aa)
Chain A1
1–893(893 aa)
Chain A2
1–893(893 aa)
Chain A3
1–893(893 aa)
Chain A4
1–893(893 aa)
Chain A5
1–893(893 aa)
Chain A6
1–893(893 aa)
Chain A7
1–893(893 aa)
Chain A8
1–893(893 aa)
Chain A9
1–893(893 aa)
Chain Ac
1–893(893 aa)
Chain Ad
1–893(893 aa)
Chain Ae
1–893(893 aa)
Chain Af
1–893(893 aa)
Chain Ag
1–893(893 aa)
Chain Ah
1–893(893 aa)
Chain Ai
1–893(893 aa)
Chain Aj
1–893(893 aa)
Chain Ak
1–893(893 aa)
Chain Al
1–893(893 aa)
Chain Am
1–893(893 aa)
Chain An
1–893(893 aa)
Chain Ap
1–893(893 aa)
Chain Aq
1–893(893 aa)
Chain Ar
1–893(893 aa)
Chain As
1–893(893 aa)
Chain At
1–893(893 aa)
Chain Au
1–893(893 aa)
Chain Av
1–893(893 aa)
Chain Aw
1–893(893 aa)
Chain Ax
1–893(893 aa)
Chain Ay
1–893(893 aa)
Chain Az
1–893(893 aa)
Chain BA
1–893(893 aa)
Chain BB
1–893(893 aa)
Chain BC
1–893(893 aa)
Chain BD
1–893(893 aa)
Chain BE
1–893(893 aa)
Chain BF
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
9R87
Cap of the vault protein from Human Brain
Deposited 2025-05-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 39
PDB declaration: 39-meric
|
Chain A
1–893(893 aa)
Chain A1
1–893(893 aa)
Chain A2
1–893(893 aa)
Chain A3
1–893(893 aa)
Chain A4
1–893(893 aa)
Chain Ar
1–893(893 aa)
Chain As
1–893(893 aa)
Chain At
1–893(893 aa)
Chain Au
1–893(893 aa)
Chain Av
1–893(893 aa)
Chain Aw
1–893(893 aa)
Chain Ax
1–893(893 aa)
Chain Ay
1–893(893 aa)
Chain Az
1–893(893 aa)
Chain B
1–893(893 aa)
Chain C
1–893(893 aa)
Chain D
1–893(893 aa)
Chain E
1–893(893 aa)
Chain F
1–893(893 aa)
Chain G
1–893(893 aa)
Chain H
1–893(893 aa)
Chain I
1–893(893 aa)
Chain J
1–893(893 aa)
Chain K
1–893(893 aa)
Chain L
1–893(893 aa)
Chain M
1–893(893 aa)
Chain N
1–893(893 aa)
Chain O
1–893(893 aa)
Chain P
1–893(893 aa)
Chain Q
1–893(893 aa)
Chain R
1–893(893 aa)
Chain S
1–893(893 aa)
Chain T
1–893(893 aa)
Chain U
1–893(893 aa)
Chain V
1–893(893 aa)
Chain W
1–893(893 aa)
Chain X
1–893(893 aa)
Chain Y
1–893(893 aa)
Chain Z
1–893(893 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|